In the latest trading session, Canopy Growth Corporation (CGC) closed at $4.64, marking a -1.49% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.19%. Elsewhere, the Dow saw an upswing of 0.09%, while the tech-heavy Nasdaq depreciated by 0.36%. Prior to today's trading, shares of the company had lost 23.29% over the past month. This has lagged the Medical sector's gain of 1.44% and the S&P 500's gain of 2.06% in that time. The investment community will be paying ...

Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline on September 20, 2024 at 1:00 p.m. (Eastern time) Company Releases Q&A About Annual Meeting Quorum Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at [email protected] SMITHS FALLS, ON, Sept. 11, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today urges its shareholders to vote ah ...

Switch to Vaporizing and Try the VENTY TUTTLINGEN, Germany, Aug. 29, 2024 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), today announced the launch of a new inaugural campaign, the Smokeless September Challenge. This initiative invites consumers to take a break from combustion throughout September and experience the advantages of vapor ...

The financial markets are closely monitoring the upcoming U.S. election, as the outcome will likely have significant implications for the broader economy. Both candidates, Donald Trump and Kamala Harris, have outlined their policies, which are expected to influence investment strategies. With projections indicating a tight race, Vice President Harris can clinch the White House. For market-savvy investors who believe her win could impact the equities markets, here are three stocks to consider if she emerges ...

Here Are Some Canadian Marijuana Stocks To Watch Mid-August What's next for marijuana stock investors as the sector's recent rise in trading has people talking. Recently there has been an increase in trading that allowed some investors to take profits. Yet in true cannabis fashion, this rise in trading was short-lived. Yet it is moments like this where newfound confidence can be found when looking to invest in legal cannabis. The growth and boom of legal cannabis are still going strong and developing day by ...

David Klein, CEO to retire at the end of the Company's fiscal year Board of Directors expresses continued confidence in the Company's strategic direction and leadership team A comprehensive CEO selection process has been initiated to identify a successor This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated June 5, 2024. SMITHS FALLS, ON, Aug. 16, 2024 /PRNewswire/ - Canopy Growth C ...

文章核心观点 - 加拿大大麻公司Canopy Growth是北美大麻行业的主要参与者之一 [5] - 公司股价自2014年上市以来经历了大幅波动,曾达到近200亿美元的市值,但目前仅为5.75亿美元 [5] - 尽管过去12个月股价上涨69%,但公司仍未实现盈利,未来能否持续上涨存在不确定性 [6] 公司业务概况 - 公司业务包括加拿大大麻、国际市场大麻、Storz & Bickel和The Works四个可报告分部 [7] - 加拿大大麻业务是公司最大收入来源,占总收入的56%,主要通过批发渠道销售,医疗大麻收入占30% [9] - Storz & Bickel和国际市场分部分别占19%和12%的收入,其中Storz & Bickel是唯一盈利的分部 [10] - 公司在美国市场的业务通过持有Canopy USA 72%股权间接运营,但由于法律限制无法在财务报表中合并 [11] 财务表现 - 最新财报显示公司亏损1.60美元/股,远高于预期0.48美元/股的亏损 [12] - 收入48.2百万美元,同比下降13%,主要由于剥离The Works业务 [13] - 尽管仍未实现盈利,但公司的毛利率和营业利润率正在不断改善 [14] 监管环境 - 美国政府正在考虑将大麻从一级管制药物调整为三级管制,但这不等同于联邦合法化 [15][16] - 即使大麻合法化,Canopy Growth在美国的业务也仍将受到限制,需要FDA批准才能合法销售医疗大麻 [16] - 未来大麻合法化的进程存在不确定性,投资者应谨慎对待Canopy Growth的美国业务 [17][28] 分析师评级 - 分析师普遍给予Canopy Growth"减持"评级,目标价较当前价格下跌33.9% [20][21][27] - 公司在加拿大市场实现盈利是首要任务,美国市场开放是影响其估值的关键因素 [29]

文章核心观点 - Tilray Brands正在扩张业务,同时在改善财务状况 [1] - Tilray Brands相比Canopy Growth而言是更好的整体投资选择 [2][3][4][5][6][7] 公司概况 - Canopy Growth的战略围绕着美国大麻合法化的希望,而Tilray Brands则专注于大麻以外的机会 [3][4] - Tilray Brands通过收购酒类品牌拓展到酒类业务,这为其带来了更高的毛利率和盈利能力 [4][5] 财务表现 - Tilray Brands的财务状况优于Canopy Growth,其营业亏损大幅收窄,收入也实现了25%的增长 [5] - 相比之下,Canopy Growth仍在通过出售资产来缩减业务规模,但盈利能力提升有限 [6] 投资价值评估 - 尽管Tilray Brands相比Canopy Growth更具投资价值,但其自身仍存在诸多不确定性,投资风险较高 [7][8][9] - 对于想要投资大麻行业的投资者而言,投资大麻ETF可能是更好的选择 [9]

Newsflash: When marijuana is legalized, Americans will buy marijuana legally. Canopy Growth (CGC 1.89%) stock inched 3.2% higher through 10:35 a.m. ET Monday after marijuana news source Marijuana Moment reported on a new positive development for the (legalized) marijuana industry: According to cannabis telehealth platform NuggMD, most Americans now prefer to buy their weed from legal sources. The legal marijuana market There are caveats to this conclusion. As Marijuana Moment describes, NuggMD's survey focu ...

Key Takeaways Canopy Growth Corporation shares dropped Friday after reporting worse-than-expected earnings. Revenues came in 13% lower than a year earlier and net loss widened substantially. Canadian adult-use cannabis sales for the company decreased, offset by an increase in medical cannabis sales Canopy Growth Corporation (CGC) shares dropped Friday after the company's first-quarter fiscal 2025 earnings fell significantly short of expectations. The cannabis producer's revenue of 66.2 million Canadian doll ...